List of articles with "Nektar Therapeutics"

Rezpegaldesleukin Data at ACAAI

Rezpegaldesleukin Data at ACAAI

USA San Francisco Nektar Therapeutics Rezpegaldesleukin ACAAI
Nektar Q3 2025 Results

Nektar Q3 2025 Results

USA San Francisco Clinical Trials Nektar Therapeutics Rezpegaldesleukin
Nektar at Jefferies 2025

Nektar at Jefferies 2025

United States San Francisco Nektar Therapeutics Immunology Jefferies Conference
Rezpegaldesleukin Data at ACAAI

Rezpegaldesleukin Data at ACAAI

United States Orlando Nektar Therapeutics Rezpegaldesleukin ACAAI 2025
Rezpegaldesleukin Insights

Rezpegaldesleukin Insights

United States San Francisco Nektar Therapeutics Rezpegaldesleukin EADV 2025
Nektar's Rezpegaldesleukin Results

Nektar's Rezpegaldesleukin Results

United States San Francisco Nektar Therapeutics Rezpegaldesleukin EADV Congress
Nektar Q2 2025 Financials

Nektar Q2 2025 Financials

United States San Francisco Nektar Therapeutics Rezpegaldesleukin NKTR-0165
Nektar Therapeutics Offering

Nektar Therapeutics Offering

United States San Francisco Immunotherapy Nektar Therapeutics NKTR-358
Nektar's $100M Offering

Nektar's $100M Offering

USA San Francisco Immunotherapy Nektar Therapeutics NKTR-358
Nektar's New Offering

Nektar's New Offering

United States biotech San Francisco Immunotherapy Nektar Therapeutics
Nektar Q1 2025 Update

Nektar Q1 2025 Update

USA San Francisco Nektar Therapeutics NKTR-358 autoimmune disorders
Nektar's Q4 2024 Results

Nektar's Q4 2024 Results

United States San Francisco Nektar Therapeutics Rezpegaldesleukin NKTR-358
Nektar Enrollment Complete

Nektar Enrollment Complete

United States San Francisco Nektar Therapeutics Alopecia Areata Rezpegaldesleukin
Nektar's Diabetes Event

Nektar's Diabetes Event

USA San Francisco Type 1 Diabetes Nektar Therapeutics Rezpegaldesleukin
Nektar and TrialNet Study

Nektar and TrialNet Study

United States San Francisco Type 1 Diabetes Nektar Therapeutics Rezpegaldesleukin
FDA Fast Track for Nektar

FDA Fast Track for Nektar

United States San Francisco FDA Nektar Therapeutics Rezpegaldesleukin
REZOLVE-AD Study Update

REZOLVE-AD Study Update

United States San Francisco Atopic Dermatitis Nektar Therapeutics Rezpegaldesleukin
Promising NKTR-255 Data

Promising NKTR-255 Data

United States San Diego CAR-T therapy Nektar Therapeutics NKTR-255
Gannet BioChem Launch

Gannet BioChem Launch

United States Huntsville Ampersand Capital Gannet BioChem Nektar Therapeutics

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.